![Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior](https://mma.prnewswire.com/media/1222835/SPRAVATO_Logo.jpg?p=facebook)
Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
![FDA approves esketamine nasal spray, the first new major depression drug in more than 30 years | TechCrunch FDA approves esketamine nasal spray, the first new major depression drug in more than 30 years | TechCrunch](https://techcrunch.com/wp-content/uploads/2019/03/Spravato.jpeg)
FDA approves esketamine nasal spray, the first new major depression drug in more than 30 years | TechCrunch
![Spravato (Esketamine) for Treatment Resistant Depression - An FDA Approved "Breakthrough Therapy" - Inspire Malibu % Spravato (Esketamine) for Treatment Resistant Depression - An FDA Approved "Breakthrough Therapy" - Inspire Malibu %](https://www.inspiremalibu.com/wp-content/uploads/2019/04/spravato-esketamine-for-treatment-resistant-depression.jpg)
Spravato (Esketamine) for Treatment Resistant Depression - An FDA Approved "Breakthrough Therapy" - Inspire Malibu %
![SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder](https://d1l0gza1nowsqe.cloudfront.net/wp-content/uploads/sites/4/2022/05/Spravato6001PPS0_620.jpg)
SPRAVATO®▽ approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder
![New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - Sandhya Prashad, MD New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - Sandhya Prashad, MD](https://sprashadmd.com/wp-content/uploads/2020/08/Spravato-_-Sandhya-Prashad-MD-social-post.png)
New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - Sandhya Prashad, MD
![SPRAVATO®: A New Option for Treatment-Resistant Depression - PAKC - Psychiatry Associates of Kansas City SPRAVATO®: A New Option for Treatment-Resistant Depression - PAKC - Psychiatry Associates of Kansas City](https://pakconline.com/wp-content/uploads/2023/01/kansas-city-ketamine-spravato-PAKC.webp)